Sandoz launches generic paclitaxel formulation in the U.S.
PremiumThe FlySandoz launches generic paclitaxel formulation in the U.S.
1M ago
Sandoz downgraded to Sector Perform from Outperform at RBC Capital
Premium
The Fly
Sandoz downgraded to Sector Perform from Outperform at RBC Capital
2M ago
Sandoz downgraded to Hold from Buy at Berenberg
Premium
The Fly
Sandoz downgraded to Hold from Buy at Berenberg
2M ago
Sandoz initiated with an Overweight at Barclays
PremiumThe FlySandoz initiated with an Overweight at Barclays
4M ago
Sandoz launches biosimilar Pyzchiva across Europe
Premium
The Fly
Sandoz launches biosimilar Pyzchiva across Europe
4M ago
Evotec Biologics expands tech partnership with Sandoz
Premium
The Fly
Evotec Biologics expands tech partnership with Sandoz
4M ago
Sandoz price target raised to CHF 38 from CHF 35 at Berenberg
PremiumThe FlySandoz price target raised to CHF 38 from CHF 35 at Berenberg
6M ago
Sandoz price target raised to CHF 36.50 from CHF 33.50 at JPMorgan
Premium
The Fly
Sandoz price target raised to CHF 36.50 from CHF 33.50 at JPMorgan
6M ago
Sandoz price target raised to CHF 32 from CHF 30 at Morgan Stanley
Premium
The Fly
Sandoz price target raised to CHF 32 from CHF 30 at Morgan Stanley
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100